Walvax Biotechnology Co Ltd

Common Name
Walvax Biotechnology
Country
China (Mainland)
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
2,388
Ticker
300142
Exchange
SHENZHEN STOCK EXCHANGE
Description
Walvax Biotechnology Co., Ltd. is a leading biopharmaceutical company based in China, focusing on the research, development, and commercialization of vaccines and biopharmaceutical products. Establish...

Walvax Biotechnology's GHG Emissions Data Preview

In 2023, Walvax Biotechnology completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources), and Scope 2 (indirect emissions from purchased energy).

However, Walvax Biotechnology has not published a category-level breakdown of its Scope 3 emissions, limiting visibility into specific value chain sources.

Metric (tCO2e)2024202320222021 - 2017
Total Scope 1
0000000
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
0000000
Total Scope 2
Unspecified Calculation Method
0000000
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
0000000
Total Scope 3
0000000
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
0000000

This table provides a simplified preview of selected GHG emissions data points. To access the complete dataset with full disclosures, detailed breakdowns, and source traceability, create a free account to view purchase options.

Insights into Walvax Biotechnology's Operational Emissions

In 2023, the total operational greenhouse gas (GHG) emissions of Walvax Biotechnology amounted to 46,013.29 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2).

Compared to 2022, the total operational greenhouse gas (GHG) emissions of Walvax Biotechnology increased by 11.75%, suggesting that the company faced challenges in reducing its emissions from its core operations.

Walvax Biotechnology's Scope 1 Emissions Over Time

2022202303 k6 k9 k12 ktCO2e-8%
  • Total Scope 1
  • Year-over-Year Change

What are Walvax Biotechnology's Scope 1 emissions?

In 2023, the total Scope 1 emissions of Walvax Biotechnology were 10,331.04 metric tons of COâ‚‚ equivalent (tCOâ‚‚e).

Compared to the previous year (2022), Walvax Biotechnology's Scope 1 emissions decreased by 8.48%, highlighting the company's efforts to lower direct emissions from assets it owns or controls.

What are Walvax Biotechnology's Scope 2 emissions?

In 2023, Walvax Biotechnology reported Scope 2 greenhouse gas (GHG) emissions of 35,682.25 tCOâ‚‚e without specifying the calculation method.

Has Walvax Biotechnology reduced its Scope 2 emissions over time?

Compared to the previous year (2022), Walvax Biotechnology's Scope 2 emissions (Unspecified Calculation Method) rose by 19.38% in 2023, suggesting that the company faced challenges in reducing emissions from purchased electricity and energy

What methodology does Walvax Biotechnology use for Scope 2 reporting?

In 2023, Walvax Biotechnology reported its Scope 2 emissions using an unspecified methodology.

Walvax Biotechnology's Scope 2 Emissions Over Time

2022202309 k18 k27 k36 ktCO2e
  • Total Scope 2 (Unspecified Calculation Method)